Novo Nordisk A/S Class B

Novo Nordisk A/S Class B

285.20

DKK

+15.05

(+5.57%)

26.20EPS

11.99P/E

1.39TMarket Cap

Feb 03Next Earn

Q4 FY2025 · Presentation 4

AGM 2026 FINAL PRESENTATION 26 MAR · 51 pages

Read Novo Nordisk A/S Class B's results firsthand

Preview the first 2 pages of this presentation
Create a free account to start reading

Full documents are included with Professional

Q4 FY2025 documents

Annual report

Form 20-F · 43 pages

Feb 4, 2026

Annual report

137 pages

Feb 4, 2026

Interim report

Novo Nordisk - Q4 2025 - Interim Report

43 pages

Feb 4, 2026

Interim report

Novo Nordisk - Q4 2025 - Interim Report

43 pages

Feb 3, 2026

Presentation 1

121 pages

Presentation 2

5 pages

Presentation 3

5 pages

Presentation 4

AGM 2026 FINAL PRESENTATION 26 MAR

51 pages

Presentation 5

121 pages

Press release

4 pages

Q4 FY2025 earnings call →